v3.21.2

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

6 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of derivative liabilities

Schedule of derivative liabilities
		September 30, 2021
The financings giving rise to derivative financial instruments		Indexed Shares				Fair Values
Compound embedded derivatives			810,258,880			$	(1,762,774	)
Total			810,258,880			$	(1,762,774	)

The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of September 30, 2020:

		September 30, 2020
The financings giving rise to derivative financial instruments		Indexed Shares				Fair Values
Compound embedded derivatives			183,301,607			$	(599,454	)
Total			183,301,607			$	(599,454	)

The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the three months ended September 30, 2021 and 2020:

The financings giving rise to derivative financial instruments and the income effects:		September 30, 2021				September 30, 2020
Compound embedded derivatives		$	(354,942	)		$	(511,975	)
Total (loss)		$	(354,942	)		$	(511,975	)

The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the six months ended September 30, 2021 and 2020:

The financings giving rise to derivative financial instruments and the income effects:		September 30, 2021				September 30, 2020
Compound embedded derivatives		$	(665,813	)		$	(787,407	)
Total (loss)		$	(665,813	)		$	(787,407	)

Significant inputs

Significant inputs
	September 30, 2021
Quoted market price on valuation date	$0.01
Contractual conversion rate	$0.00265-$0.01
Contractual term to maturity	0.005 Years – 1.0 Years
Market volatility:
Equivalent Volatility	93.44% - 184.40%
Interest rate	8.00%

Schedule of changes in fair value of derivatives

Schedule of changes in fair value of derivatives
		September 30,				March 31,
		2021				2021
Beginning balance		$	1,137,623			$	58,790
Issuances:
Compound embedded derivatives			407,194				732,416
Conversions			–				(859,352	)
Derivative extinguished / debt repaid in cash			(136,666	)			(126,892	)
(Gain) loss on changes in fair value inputs and assumptions reflected in income			354,942				1,332,661
Total		$	1,763,093			$	1,137,623

X

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all information related to the key inputs and assumptions (including, at a minimum, but not limited to, and if applicable, quantitative information about discount rates, expected prepayments including the expected weighted-average life of prepayable financial assets, and anticipated credit losses) used in measuring the fair value of assets or liabilities that relate to the transferor's continuing involvement with transferred financial assets, as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719

+ Details

Name:	us-gaap_ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of derivative liabilities at fair value.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration